Director/PDMR Shareholding

RNS Number : 0225P
Hikma Pharmaceuticals Plc
23 May 2018
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Castellani

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Market purchase of 1,000 Ordinary Shares by Brown Advisory Investment Management Firm for and on behalf of John and Therese Castellani.

c)

Price(s) and volume(s)

Price(s): £13.7695

Volume(s): 1,000

d)

Aggregated information

-       Volume

-       Price



1,000


£13,769.50

e)

Date of the transaction

22 May 2018

f)

Place of the transaction

London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGCGDUCBDBGIX
UK 100

Latest directors dealings